| 1 | Gut Microbiome Remodeling to Prevent Systemic NLRP3 Priming in Neurodegeneration h-var-08a4d5c07a | NLRP3, CASP1, IL1B, PYCARD | validated | 0.924 | 2026-05-13 | Open → |
| 2 | APOE-Dependent Autophagy Restoration h-51e7234f | MTOR | validated | 0.895 | 2026-05-16 | Open → |
| 3 | p38α Inhibitor and PRMT1 Activator Combination to Restore Physiological TDP-43… h-ccc05373 | MAPK14/PRMT1 | validated | 0.895 | 2026-05-16 | Open → |
| 4 | SIRT1-Mediated Reversal of TREM2-Dependent Microglial Senescence h-var-b7de826706 | SIRT1 | validated | 0.893 | 2026-05-16 | Open → |
| 5 | TREM2-Mediated Astrocyte-Microglia Crosstalk in Neurodegeneration h-var-66156774e7 | TREM2 | validated | 0.892 | 2026-05-16 | Open → |
| 6 | TREM2-APOE Axis Dissociation for Selective DAM Activation h-5b378bd3 | TREM2-APOE axis | validated | 0.886 | 2026-05-13 | Open → |
| 7 | Circadian Glymphatic Entrainment via Targeted Orexin Receptor Modulation h-9e9fee95 | HCRTR1/HCRTR2 | validated | 0.882 | 2026-05-13 | Open → |
| 8 | Senescent Cell ASM-Complement Cascade Intervention h-var-76afa28dfc | SMPD1 | validated | 0.852 | 2026-05-16 | Open → |
| 9 | Prime Editing Precision Correction of APOE4 to APOE3 in Microglia h-42f50a4a | APOE | validated | 0.850 | 2026-05-16 | Open → |
| 10 | Neutral Sphingomyelinase-2 Inhibition for Synaptic Protection in Neurodegenerat… h-var-e81fbd3868 | SMPD3 | validated | 0.844 | 2026-05-16 | Open → |
| 11 | TYROBP (DAP12) Conditional Antagonism for Early-Stage Neuroprotection h-f503b337 | TYROBP | validated | 0.844 | 2026-05-13 | Open → |
| 12 | AMPK hypersensitivity in astrocytes creates enhanced mitochondrial rescue respo… h-43f72e21 | PRKAA1 | validated | 0.833 | 2026-05-16 | Open → |
| 13 | Microglial AIM2 Inflammasome as the Primary Driver of TDP-43 Proteinopathy Neur… h-var-a0933e666d | AIM2, CASP1, IL1B, PYCARD, TARDBP | validated | 0.824 | 2026-05-16 | Open → |
| 14 | SASP-Mediated Complement Cascade Amplification h-58e4635a | C1Q/C3 | validated | 0.822 | 2026-05-16 | Open → |
| 15 | Astrocyte-Intrinsic NLRP3 Inflammasome Activation by Alpha-Synuclein Aggregates… h-var-adfecef68a | NLRP3, CASP1, IL1B, PYCARD | validated | 0.822 | 2026-05-13 | Open → |
| 16 | HSPB1 Phosphorylation Mimetics to Promote Protective TDP-43 Liquid-Liquid Phase… h-ff0d545d | HSPB1 | validated | 0.820 | 2026-05-14 | Open → |
| 17 | Extracellular Vesicle Biogenesis Modulation SDA-2026-04-02-gap-tau-prop-20260402003221-H003 | CHMP4B | validated | 0.814 | 2026-05-16 | Open → |
| 18 | CLU/APOE Duality in Amyloid Clearance Determines Cell-Type-Specific Vulnerabili… h-0bcda2e0 | APOE, CLU | validated | 0.811 | 2026-05-13 | Open → |
| 19 | LRP1-Dependent Tau Uptake Disruption SDA-2026-04-02-gap-tau-prop-20260402003221-H001 | LRP1 | validated | 0.808 | 2026-05-16 | Open → |
| 20 | CSF1R-TREM2 Co-Agonism for Sustained Microglial Expansion h-0cbe9bac | CSF1R-TREM2 | validated | 0.808 | 2026-05-16 | Open → |
| 21 | Beta-Hydroxybutyrate Receptor (HCAR2) Signaling Links Ketone Deficiency to Neur… h-5b35f7a5 | HCAR2 | validated | 0.808 | 2026-05-13 | Open → |
| 22 | Mitochondrial DAMPs-Driven AIM2 Inflammasome Activation in Neurodegeneration h-var-6957745fea | AIM2, CASP1, IL1B, PYCARD | validated | 0.805 | 2026-05-13 | Open → |
| 23 | Targeted Butyrate Supplementation for Microglial Phenotype Modulation h-3d545f4e | GPR109A | promoted | 0.805 | 2026-05-16 | Open → |
| 24 | Calcium-Dysregulated mPTP Opening as an Alternative mtDNA Release Mechanism for… h-var-af9eb8e59b | AIM2, CASP1, IL1B, PYCARD, PPIF | validated | 0.804 | 2026-05-13 | Open → |
| 25 | TREM2-mTOR Co-Agonism for Metabolic Reprogramming h-2e03f316 | TREM2-mTOR pathway | validated | 0.803 | 2026-05-13 | Open → |
| 26 | Mitochondrial DNA-Driven AIM2 Inflammasome Activation in Neurodegeneration h-var-d04a952932 | AIM2, CASP1, IL1B, PYCARD | validated | 0.803 | 2026-05-13 | Open → |
| 27 | Microglial TREM2-SYK Pathway Enhancement h-48858e2a | TREM2 | promoted | 0.798 | 2026-05-14 | Open → |
| 28 | Selective APOE4 Degradation via Proteolysis Targeting Chimeras (PROTACs) h-11795af0 | APOE | promoted | 0.795 | 2026-05-13 | Open → |
| 29 | Targeting SASP-Complement Amplification Through HIF-1α Downstream Effectors h-a9f2570b | C1QA, C1QB, C3, IL1B | promoted | 0.793 | 2026-05-14 | Open → |
| 30 | Senescent Microglia Resolution via Maresins-Senolytics Combination h-3f02f222 | BCL2L1 | debated | 0.791 | 2026-05-16 | Open → |
| 31 | Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming h-f3fb3b91 | TLR4 | proposed | 0.789 | 2026-05-13 | Open → |
| 32 | VCP-Mediated Autophagy Enhancement SDA-2026-04-02-gap-tau-prop-20260402003221-H004 | VCP | proposed | 0.787 | 2026-05-16 | Open → |
| 33 | Competitive APOE4 Domain Stabilization Peptides h-d0a564e8 | APOE | promoted | 0.784 | 2026-05-13 | Open → |
| 34 | Integrated Biomarker Panel for Therapeutic Window Identification h-ecd9ed6c | CHI3L1 | promoted | 0.784 | 2026-05-13 | Open → |
| 35 | SASP-Driven Aquaporin-4 Dysregulation h-807d7a82 | AQP4 | promoted | 0.782 | 2026-05-13 | Open → |
| 36 | Selective Acid Sphingomyelinase Modulation Therapy h-de0d4364 | SMPD1 | promoted | 0.782 | 2026-05-16 | Open → |
| 37 | TREM2-mediated microglial tau clearance enhancement SDA-2026-04-02-gap-tau-prop-20260402003221-H002 | TREM2 | proposed | 0.780 | 2026-05-16 | Open → |
| 38 | TFEB Nuclear Translocation to Reset Lysosomal-Hypoxia Axis h-810ec0eb | TFEB, MTOR | promoted | 0.779 | 2026-05-14 | Open → |
| 39 | Selective HDAC3 Inhibition with Cognitive Enhancement h-0e675a41 | HDAC3 | promoted | 0.779 | 2026-05-16 | Open → |
| 40 | SIRT1/PGC-1α Axis Activation to Preserve Mitochondrial Resiliency Against Micro… h-26b9f3e7 | SIRT1, PGC-1α (PPARGC1A), NAMPT | promoted | 0.778 | 2026-05-13 | Open → |
| 41 | Transcriptional Autophagy-Lysosome Coupling h-ae1b2beb | FOXO1 | promoted | 0.777 | 2026-05-16 | Open → |
| 42 | CX3CR1-TREM2 Integration for Synapse Pruning Normalization h-7597968b | CX3CR1-TREM2 | proposed | 0.776 | 2026-05-16 | Open → |
| 43 | Dual-Domain Antibodies with Engineered Fc-FcRn Affinity Modulation h-23a3cc07 | FCGRT | promoted | 0.773 | 2026-05-16 | Open → |
| 44 | Chromatin Accessibility Restoration via BRD4 Modulation h-addc0a61 | BRD4 | promoted | 0.768 | 2026-05-16 | Open → |
| 45 | CYP46A1 Overexpression Gene Therapy h-2600483e | CYP46A1 | promoted | 0.768 | 2026-05-16 | Open → |
| 46 | HDL/apoE Particle Remodeling as a Therapeutic Switch for CAA Prevention h-ed8dee29 | ABCA1 | proposed | 0.766 | 2026-05-14 | Open → |
| 47 | APOE4 Allosteric Rescue via Small Molecule Chaperones h-44195347 | APOE | debated | 0.765 | 2026-05-13 | Open → |
| 48 | Chromatin Remodeling-Mediated Nutrient Sensing Restoration h-var-a09491064e | SMARCA4 | promoted | 0.764 | 2026-05-16 | Open → |
| 49 | SASP-Mediated Cholinergic Synapse Disruption h-1acdd55e | MMP2/MMP9 | promoted | 0.763 | 2026-05-13 | Open → |
| 50 | Circadian Clock-Autophagy Synchronization h-b7898b79 | CLOCK | debated | 0.763 | 2026-05-13 | Open → |